Navigating the regulatory requirements of Clinical Trial Applications (CTAs) in Canada can be challenging to sponsors. Submission of high-quality CTAs is essential for an efficient drug development process and benefits both Health Canada and the industry.

This short course offers a comprehensive exploration of the different aspects of Clinical Trial Applications (CTAs) in Canada including clinical, quality, and publishing and provides a unique opportunity to hear the perspective of both Health Canada and the industry.

Through a combination of Health Canada and Industry speakers, the course will inform professionals in the pharmaceutical, and biotechnology industries, as well as clinical researchers and regulatory affairs specialists, on the requirements and best practices for CTA in Canada.

By the end of the course, the participants will have learned how to address challenges, avoid pitfalls and adopt strategies to ensure the preparation and submission of a high-quality CTA.

Registered attendees for this virtual Short Course will receive access to the course recording for 2 full months post-course! This allows you to remain flexible with your schedule and not worry if you need to step out momentarily. Have a conflict with the dates of the course, but are interested in the content? Register anyway and you will receive access to the recording! Note: You do not need to register for the full Canada Annual Meeting to attend this Virtual Short Course.